Therapeutic Advances in Drug Safety
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.3 | Q2 | 58.4% | 0.833 | Q2 | 78.6% |
| 2024 | 3.4 | Q2 | 68.3% | 1.165 | Q1 | 87.8% |
| 2023 | 3.4 | Q2 | 71.3% | 1.035 | Q1 | 86.4% |
| 2022 | 4.4 | Q2 | 76.3% | 0.715 | Q2 | 77.4% |
| 2021 | 3.2 | Q3 | 53.7% | 0.837 | Q2 | 82.3% |
| 2020 | — | — | 1.196 | Q1 | 88.9% | |
| 2019 | — | — | 1.072 | Q1 | 87.1% | |
| 2018 | — | — | 1.131 | Q1 | 86.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2042-0994
ISSN
2042-0986
country
GBcoverage
2010-2026